P
Phylos Bioscience
Cannabis genetics company that empowers growers of all sizes to produce high quality cannabis in a cost-effective way
About Phylos Bioscience
Phylos Bioscience operates at the intersection of agricultural science and data technology, focusing specifically on the cannabis and hemp industries. Founded in 2014 by Nishan Karassik and Mowgli Holmes, the company initially aimed to create a comprehensive genetic map of the cannabis plant, similar to a 23andMe for cannabis. Nishan Karassik's background in technology and sustainable agriculture, combined with Mowgli Holmes's expertise as a molecular biologist, provided the foundational knowledge for this endeavor. Holmes, who holds a PhD from Columbia University, was driven by the potential to apply modern genomic science to a plant with a long, yet poorly documented, history of cultivation.
The company's core business revolves around providing genomic testing and data services to cultivators, breeders, and researchers within the cannabis market. Its primary offering is a suite of genetic tests that can identify a plant's lineage, cannabinoid and terpene profiles, and sex. This information empowers growers to make more informed decisions, optimize their cultivation practices for desired traits, and protect their intellectual property. The business model is primarily service-based, generating revenue from the sale of these testing kits and the associated data analysis. Phylos serves a diverse clientele, ranging from large-scale commercial growers to smaller craft producers and research institutions.
A significant development in the company's trajectory was the introduction of its own proprietary cannabis seeds. This move represented a strategic pivot from being purely a data and testing provider to also becoming a direct supplier of plant genetics. This vertical integration allows Phylos to leverage its vast genetic database to breed new varieties with specific, commercially desirable characteristics, such as high yields or specific chemical profiles. This expansion into seed production provides a new and substantial revenue stream, positioning the company as a key player in the supply chain for cannabis cultivation. The company's database, known as The Phylos Galaxy, has been a central part of its identity, mapping the genetic relationships between thousands of cannabis strains and making this information accessible to its clients.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Portland, United States
- Employees
- 49
- Open positions
- None listed
- Dealroom signal
- 72.6/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Testing, Biotechnology, Research and Development, Cannabis, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| CONVERTIBLE✓Equity / VC | Jul 2024 | $1M | — | OrganiGram | ↗ |
| CONVERTIBLE✓Equity / VC | Nov 2023 | $2.8M | — | OrganiGram | ↗ |
Growth signals
Latest recorded traffic for Phylos Bioscience is 17K monthly website visits, up 153.7% over the last three months. Phylos Bioscience's team grew 2.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
OrganiGram
Series B and later4 investors entered at this stage
Slow Ventures- MPMerida Capital Partners
Accomplice
Entourage Effect Capital
Other known investors1 additional known investor
Big Rock
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Phylos Bioscience on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Phylos Bioscience’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







